ASTM E1482-23
(Practice)Standard Practice for Use of Gel Filtration Columns for Cytotoxicity Reduction and Neutralization
Standard Practice for Use of Gel Filtration Columns for Cytotoxicity Reduction and Neutralization
SIGNIFICANCE AND USE
5.1 This practice is to be used for the removal of virucidal agents from test product-virus mixtures, or from test product-neutralizer-virus mixtures, at or after the contact period and before the inoculation of these mixtures into host systems for assay of viral infectivity.
5.2 The purpose of the practice is to reduce the concentration of the cytotoxic properties of the test product and neutralizers in order to permit the evaluation of viral infectivity at dilutions that would otherwise be toxic to the host cells.
5.3 The practice is applicable to the testing of liquid, pre-saturated towelettes, and pressurized disinfectant products, as well as handwash/rub products.
Note 3: When testing products, the ability of the solution to pass through the column must be verified prior to testing. Certain products with high viscosities are unable to pass through columns. If the product is determined to be too viscous, alternative neutralization methods should be employed.
5.4 This practice is compatible with organic soil loads, hard water, disinfectants containing organic solvents, and chemical neutralizers.
SCOPE
1.1 This practice is intended to be used to reduce the cytotoxic level of the virus-test product mixture prior to assaying for viral infectivity. It is used in conjunction with evaluations of the virucidal efficacy of disinfectant solutions, wipes, trigger sprays, or pressurized disinfectant spray products intended for use on inanimate, nonporous environmental surfaces. This practice may also be used in the evaluation of hygienic handwashes/handrubs, or for other special applications. The practice may be employed with all viruses and host systems.
Note 1: Gel filtration columns may impact virus titer and their use should be taken into consideration when selected for use.
1.2 This practice should be performed only by persons trained in virology techniques.
1.3 This practice utilizes gel filtration technology. The effectiveness of the practice is dependent on the ratio of gel bed volume to sample size and uniformity in the preparation of columns as well as the conditions of centrifugation. The effectiveness of this practice is maximized by investigator practice and experience with gel filtration techniques.
1.4 This practice will aid in the reduction, but not necessarily elimination, of test product toxicity while preserving the titer of the input virus.
1.5 Units—The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.7 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
General Information
Buy Standard
Standards Content (Sample)
This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the
Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Designation: E1482 − 23
Standard Practice for
Use of Gel Filtration Columns for Cytotoxicity Reduction
1,2
and Neutralization
This standard is issued under the fixed designation E1482; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope 1.7 This international standard was developed in accor-
dance with internationally recognized principles on standard-
1.1 This practice is intended to be used to reduce the
ization established in the Decision on Principles for the
cytotoxic level of the virus-test product mixture prior to
Development of International Standards, Guides and Recom-
assaying for viral infectivity. It is used in conjunction with
mendations issued by the World Trade Organization Technical
evaluations of the virucidal efficacy of disinfectant solutions,
Barriers to Trade (TBT) Committee.
wipes, trigger sprays, or pressurized disinfectant spray prod-
ucts intended for use on inanimate, nonporous environmental
2. Referenced Documents
surfaces. This practice may also be used in the evaluation of
3
2.1 ASTM Standards:
hygienic handwashes/handrubs, or for other special applica-
E1052 Practice to Assess the Activity of Microbicides
tions. The practice may be employed with all viruses and host
against Viruses in Suspension
systems.
E1053 Practice to Assess Virucidal Activity of Chemicals
NOTE 1—Gel filtration columns may impact virus titer and their use
Intended for Disinfection of Inanimate, Nonporous Envi-
should be taken into consideration when selected for use.
ronmental Surfaces
1.2 This practice should be performed only by persons
E2756 Terminology Relating to Antimicrobial and Antiviral
trained in virology techniques.
Agents
1.3 This practice utilizes gel filtration technology. The
3. Terminology
effectiveness of the practice is dependent on the ratio of gel bed
volume to sample size and uniformity in the preparation of 3.1 Definitions:
columns as well as the conditions of centrifugation. The 3.1.1 For definitions of terms used in this guide, refer to
effectiveness of this practice is maximized by investigator Terminology E2756.
practice and experience with gel filtration techniques.
4. Summary of Test Practice
1.4 This practice will aid in the reduction, but not necessar-
4.1 After the exposure of a virus to a test product, the
ily elimination, of test product toxicity while preserving the
4
virus-product suspension is added to a column of Sephadex
titer of the input virus.
4
LH-60, Sephadex LH-20, or other appropriate gel filtration
1.5 Units—The values stated in SI units are to be regarded
medium. The column (encased within a sterile centrifuge tube
as standard. No other units of measurement are included in this
in order to capture the filtrate) is placed in a centrifuge and
standard.
centrifuged to separate the virus from the test product by gel
1.6 This standard does not purport to address all of the
filtration. Alternatively, samples may be hand-plunged using a
safety concerns, if any, associated with its use. It is the
syringe plunger. The filtrate (the column flow-through which
responsibility of the user of this standard to establish appro-
contains the virus) is assayed in the appropriate host system.
priate safety, health, and environmental practices and deter-
The untreated virus control suspension is gel-column filtered,
mine the applicability of regulatory limitations prior to use.
3
For referenced ASTM standards, visit the ASTM website, www.astm.org, or
contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM
1
This practice is under the jurisdiction of ASTM Committee E35 on Pesticides, Standards volume information, refer to the standard’s Document Summary page on
Antimicrobials, and Alternative Control Agents and is the direct responsibility of the ASTM website.
4
Subcommittee E35.15 on Antimicrobial Agents. Sephadex is a registered trademark of Amersham Biosciences. The sole source
Current edition approved April 1, 2023. Published April 2023. Originally of supply of the apparatus known to the committee at this time is Amersham
approved in 1992. Last previous edition approved in 2017 as E1482 – 12 (2017). Biosciences. If you are aware of alternative suppliers, please provide this informa-
DOI: 10.1520/E1482-23. tion to ASTM International Headquarters. Your comments will receive careful
2 1
The title was formerly Standard Test Method for Neutralization of Virucidal consideration at a meeting of the responsible
...
This document is not an ASTM standard and is intended only to provide the user of an ASTM standard an indication of what changes have been made to the previous version. Because
it may not be technically possible to adequately depict all changes accurately, ASTM recommends that users consult prior editions as appropriate. In all cases only the current version
of the standard as published by ASTM is to be considered the official document.
Designation: E1482 − 12 (Reapproved 2017) E1482 − 23
Standard Practice for
Use of Gel Filtration Columns for Cytotoxicity Reduction
1,2
and Neutralization
This standard is issued under the fixed designation E1482; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope
NOTE 1—The title was formerly Standard Test Method for Neutralization of Virucidal Agents in Virucidal Efficacy Evaluations.
1.1 This practice is intended to be used to reduce the cytotoxic level of the virus-test product mixture prior to assaying for viral
infectivity. It is used in conjunction with evaluations of the virucidal efficacy of disinfectant solutions, wipes, trigger sprays, or
pressurized disinfectant spray products intended for use on inanimate, nonporous environmental surfaces. This practice may also
be used in the evaluation of hygienic handwashes/handrubs, or for other special applications. The practice may be employed with
all viruses and host systems.
NOTE 1—Gel filtration columns may impact virus titer and their use should be taken into consideration when selected for use.
1.2 This practice should be performed only by persons trained in virology techniques.
1.3 This practice utilizes gel filtration technology. The effectiveness of the practice is dependent on the ratio of gel bed volume
to sample size and uniformity in the preparation of columns as well as the conditions of entrifugation.centrifugation. The
effectiveness of this practice is maximized by investigator practice and experience with gel filtration techniques.
1.4 This practice will aid in the reduction, but not necessarily elimination, of test product toxicity while preserving the titer of the
input virus.
1.5 Units—The values stated in SI units are to be regarded as standard. No other units of measurement are included in this
standard.
1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility
of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of
regulatory limitations prior to use.
1.7 This international standard was developed in accordance with internationally recognized principles on standardization
established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued
by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
1
This practice is under the jurisdiction of ASTM Committee E35 on Pesticides, Antimicrobials, and Alternative Control Agents and is the direct responsibility of
Subcommittee E35.15 on Antimicrobial Agents.
Current edition approved Nov. 1, 2017April 1, 2023. Published December 2017April 2023. Originally approved in 1992. Last previous edition approved in 20122017 as
E1482 – 12.E1482 – 12 (2017). DOI: 10.1520/E1482-12R17.10.1520/E1482-23.
2
The title was formerly Standard Test Method for Neutralization of Virucidal Agents in Virucidal Efficacy Evaluations.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1
---------------------- Page: 1 ----------------------
E1482 − 23
2. Referenced Documents
3
2.1 ASTM Standards:
E1052 Practice to Assess the Activity of Microbicides against Viruses in Suspension
E1053 Practice to Assess Virucidal Activity of Chemicals Intended for Disinfection of Inanimate, Nonporous Environmental
Surfaces
E2756 Terminology Relating to Antimicrobial and Antiviral Agents
3. Terminology
3.1 Definitions:
3.1.1 For definitions of terms used in this guide, refer to Terminology E2756.
4. Summary of Test MethodsPractice
4.1 After the exposure of a virus to a test product (or handwash/rub product), product, the virus-product suspension is added to
4 4
a column of Sephadex LH-60, Sephadex LH-20, or Sephacrylother S-1000 Superfine. appropriate gel filtration medium. The
column (encased within a sterile centrifuge tube in order to capture the filtrate) is placed in a centrifuge and centrifuged to separate
the virus from the test product by gel filtration. Alternatively, samples may be hand-plunged using a syringe plunger. The filtrate
(the column flow-through which contains the virus) is assayed in the appropriate host system. The untreated virus control
suspension i
...
Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.